Drawing for VERA

USPTO serial 98072584

VERA

Reviewed by CopyMark Law Group

Status 774
Filing date
Status date
Registration date
—
Examiner
AURAND, KYLE C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ANTHONY LAURENTANO

ANTHONY LAURENTANO NELSON MULLINS RILEY & SCARBOROUGH LLPONE FINANCIAL CENTERSUITE 3500BOSTON, MA 02111

Goods and services

ClassDescriptionStatusFirst use
010Surgical robotsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 21, 2024ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Oct 21, 2024OP.IOPPOSITION INSTITUTED NO. 999999—
May 23, 2024ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 23, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 18, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 2024DOCKASSIGNED TO EXAMINER—
Aug 6, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 10, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance